3-FPM: Difference between revisions
>Unity Removed header panel. |
>Unity Grammatics. Fixed stub. |
||
Line 1: | Line 1: | ||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/3-FPM}} | {{SubstanceBox/3-FPM}} | ||
'''3-Fluorophenmetrazine''' (also known as '''3F-Phenmetrazine''', '''PAL-593''', and '''3-FPM''') is a novel [[psychoactive class::stimulant]] substance of the [[Chemical class::phenylmorpholine]] class. 3-FPM is a derivative of [[phenmetrazine]], a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s.<ref>Kalant, Oriana Josseau (1966). The Amphetamines: Toxicity and Addiction. ISBN 0-398-02511-8.</ref> It produces its activity by increasing the levels of [[serotonin]], [[dopamine]], and [[norepinephrine]] in the brain. | '''3-Fluorophenmetrazine''' (also known as '''3F-Phenmetrazine''', '''PAL-593''', and '''3-FPM''') is a novel [[psychoactive class::stimulant]] substance of the [[Chemical class::phenylmorpholine]] class. 3-FPM is a derivative of [[phenmetrazine]], a once-popular stimulant substance that was clinically used as an anorectic in Europe in the 1950s.<ref>Kalant, Oriana Josseau (1966). The Amphetamines: Toxicity and Addiction. ISBN 0-398-02511-8.</ref> It produces its activity by increasing the levels of [[serotonin]], [[dopamine]], and [[norepinephrine]] in the brain. | ||
The synthesis and pharmacology of 3-FPM was first reported in a patent filed in 2011.<ref>Blough, B. E., Rothman, R., Landavazo, A., Page, K. M., & Decker, A. M. (2017). U.S. Patent No. 9,617,229. Washington, DC: U.S. Patent and Trademark Office.</ref> Reports of human use first surfaced in early 2015 after it appeared for sale on the online [[research chemical]] market. | The synthesis and pharmacology of 3-FPM was first reported in a patent filed in 2011.<ref>Blough, B. E., Rothman, R., Landavazo, A., Page, K. M., & Decker, A. M. (2017). U.S. Patent No. 9,617,229. Washington, DC: U.S. Patent and Trademark Office.</ref> Reports of human use first surfaced in early 2015 after it appeared for sale on the online [[research chemical]] market. | ||
[[Subjective effects]] include [[stimulation]], [[focus enhancement|enhanced focus]] and [[motivation enhancement|motivation]], [[thought acceleration]], and [[euphoria]]. Users commonly report that 3-FPM produces classical stimulant effects comparable to those of amphetamine. Many reports describe 3-FPM as having a relatively subtle and controlled stimulant effect which produces less nervousness, insomnia and euphoria than other stimulants, which makes it suitable as a study-aid or productivity-enhancer. | |||
Very little data exists | Very little data exists about the pharmacological properties, metabolism, and toxicity of 3-FPM. Due to the lack of information on its properties, it is highly advised to use [[harm reduction practices]] if using this substance. | ||
==Chemistry== | ==Chemistry== | ||
Line 35: | Line 34: | ||
==Subjective effects== | ==Subjective effects== | ||
{{ | {{EffectStub}} | ||
According to anecdotal reports, 3-FPM is considered to be more subtle in its effects when compared to other stimulants and produces less [[anxiety|nervousness]], [[euphoria]], and [[wakefulness|insomnia]] than substances of the [[substituted amphetamine]] class, leading to its adoption as a study and productivity-enhancing drug as opposed to the more typical recreational stimulant with pronounced [[euphoric]] properties. | According to anecdotal reports, 3-FPM is considered to be more subtle in its effects when compared to other stimulants and produces less [[anxiety|nervousness]], [[euphoria]], and [[wakefulness|insomnia]] than substances of the [[substituted amphetamine]] class, leading to its adoption as a study and productivity-enhancing drug as opposed to the more typical recreational stimulant with pronounced [[euphoric]] properties. | ||